By The Gauteng Department of Health has formally acknowledged ongoing medicine supply constraints affecting public health facilities across the province. Driven by shifts in pharmaceutical contracts, supplier delays, procurement lead times, limited supplier participation, and broader supply-chain pressures, these challenges have raised concerns among patients who rely heavily on chronic treatments.
In response, provincial authorities have rolled out proactive tracking and intervention mechanisms to stabilize drug availability.
Monitoring and Tracking Systems
To catch shortages early, the Department utilizes the Stock Visibility System, which gives real-time insights into stock levels and triggers prompt escalation. These provincial efforts operate in tandem with national mechanisms, including the National Department of Health’s surveillance network, the National Surveillance Centre, and the designated national “Hot List” tracking critical items.
Protocol and Alternative Solutions
Department officials emphasize that a temporary shortfall of a specific brand, pack size, or supplier does not equate to a complete absence of patient care. Under the Medicine Availability and Escalation Protocol, clinicians can dispense:
- Approved therapeutic alternatives that align strictly with standard treatment guidelines.
- Alternative pack sizes and strengths matching the active ingredients and therapeutic benefits needed.
- Medicines from different approved manufacturers to bridge supply gaps seamlessly.
Logistics and Inter-Facility Support
When shortages hit specific locations, the Department executes dynamic logistical adjustments. Available stock is actively rotated across facilities and districts to balance inventories and cut down on wastage. Furthermore, facilities are directly engaging suppliers to fast-track outstanding orders, while targeted “buy-outs”—sourcing urgent stock from alternative approved suppliers—are deployed through standard supply chain processes.
The National Department of Health is concurrently working with manufacturers and the Improved Medicine Availability Team to investigate alternative registered suppliers and champion the rational use of existing stock.
While acknowledging that supply disruptions cause anxiety for patients, the Gauteng Department of Health maintains its dedication to continuity of care, assuring the public that rigorous oversight and collaborative mitigation measures are underway.
